← FDA DRUG APPROVALS
FDA ANDA · ANDA062539
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
Sponsor: PHARMAFAIR
APPLICATION
ANDA062539
TYPE
ANDA
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATEDiscontinued
DEXAMETHASONE SODIUM PHOSPHATE EQ 0.1% PHOSPHATE, NEOMYCIN SULFATE EQ 3.5MG BASE/ML · SOLUTION/DROPS · OPHTHALMIC
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.